Francesca Bagnato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francesca Bagnato has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
Junzhong Xu
Vanderbilt Institute of Imaging Science, Department of Radiology and Radiological Science, VUMC Nashville Tennessee USA
9 shared publications- Ahmad Amjed Toubasi
Department of Neurology, Vanderbilt University Medical Center (VUMC), Nashville, USA
8 shared publications Caroline Gheen
Neuroimaging Unit, Neuroimmunology Division, Department of Neurology Vanderbilt University Medical Center (VUMC) Nashville Tennessee USA
8 shared publicationsTaegan Vinarsky
Neuroimaging Unit, Neuroimmunology Division, Department of Neurology Vanderbilt University Medical Center (VUMC) Nashville Tennessee USA
8 shared publicationsSeth A. Smith
Neuroimaging Unit, Division of Neuroimmunology, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, United States
6 shared publications- Susan A. Gauthier
Department of Neurology Weill Cornell Medicine New York New York USA
5 shared publications
Latest Publications
- 22 August 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Implementation of a pilot online educational program to identify paramagnetic rim lesions
Background: Paramagnetic rim lesions are a highly specific magnetic resonance imaging biomarker for multiple sclerosis now incorporated into the 2024 McDonald Criteria. However, paramagnetic rim lesion identification remains underutilized in clinical practice. This study evaluates the effectiveness of an online, educational platform for improving paramagnetic rim lesion identification. Design/methods: We conducted a prospective pre-post intervention study using a web-based, asynchronous educational platform. The intervention included baseline assessment, didactic education on paramagnetic rim lesion identification, interactive case-based learning with 10 examples, and post-intervention assessment. The primary efficacy endpoint was ⩾80% of participants achieving ⩾80% accuracy on post-intervention assessment. Wilcoxon signed-rank test was used to compare pre- and post-intervention scores. Results: A total of 182 participants completed the educational intervention. The proportion of respondents achieving the primary efficacy endpoint increased from 65% (n = 118) to 91% (n = 166) (McNemar’s χ 2 = 36.8, p < 0.001). Mean accuracy scores improved significantly from 3.84 ± 0.85 (76.8%) to 4.39 ± 0.77 (87.8%) correct responses out of 5 (mean difference = 0.55 points, 95% confidence interval = [0.43, 0.67], p < 0.001). Conclusions: In this pilot study, an interactive web-based educational platform improved healthcare providers’ ability to identify paramagnetic rim lesions, with 91% achieving target proficiency. This scalable approach can facilitate broader implementation of the 2024 McDonald Criteria in clinical practice.
- 22 August 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
Implementation of a pilot online educational program to identify paramagnetic rim lesions
Background: Paramagnetic rim lesions are a highly specific magnetic resonance imaging biomarker for multiple sclerosis now incorporated into the 2024 McDonald Criteria. However, paramagnetic rim lesion identification remains underutilized in clinical practice. This study evaluates the effectiveness of an online, educational platform for improving paramagnetic rim lesion identification. Design/methods: We conducted a prospective pre-post intervention study using a web-based, asynchronous educational platform. The intervention included baseline assessment, didactic education on paramagnetic rim lesion identification, interactive case-based learning with 10 examples, and post-intervention assessment. The primary efficacy endpoint was ⩾80% of participants achieving ⩾80% accuracy on post-intervention assessment. Wilcoxon signed-rank test was used to compare pre- and post-intervention scores. Results: A total of 182 participants completed the educational intervention. The proportion of respondents achieving the primary efficacy endpoint increased from 65% (n = 118) to 91% (n = 166) (McNemar’s χ 2 = 36.8, p < 0.001). Mean accuracy scores improved significantly from 3.84 ± 0.85 (76.8%) to 4.39 ± 0.77 (87.8%) correct responses out of 5 (mean difference = 0.55 points, 95% confidence interval = [0.43, 0.67], p < 0.001). Conclusions: In this pilot study, an interactive web-based educational platform improved healthcare providers’ ability to identify paramagnetic rim lesions, with 91% achieving target proficiency. This scalable approach can facilitate broader implementation of the 2024 McDonald Criteria in clinical practice.
- Open Access
- 1 June 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (10) , 993-1007
Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities
The spinal cord plays a central role in the pathophysiology and clinical manifestations of multiple sclerosis (MS), yet remains under-studied compared with the brain. This review summarizes key insights from the 2025 North American Imaging in MS Spinal Cord Imaging Workshop, highlighting recent advances, ongoing challenges, and future opportunities in MS spinal cord imaging. We review pathological studies and outline the clinical relevance of spinal cord lesions and atrophy for diagnosis, prognosis, and disease monitoring, highlighting emerging biomarkers of progression independent of relapse activity. Correlations between magnetic resonance imaging, histopathology, and clinical outcomes support the validation and translational potential of advanced spinal cord imaging techniques. Finally, we discuss spinal cord–specific processing pipelines and reproducibility challenges. Collectively, these insights underscore the need to integrate advanced and quantitative spinal cord imaging into clinical trials, research studies, and—when feasible—clinical care, to fully capture the extent of MS pathology, and ultimately improve patient outcomes.
- 1 June 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (10) , 993-1007
Open AccessSpinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities
The spinal cord plays a central role in the pathophysiology and clinical manifestations of multiple sclerosis (MS), yet remains under-studied compared with the brain. This review summarizes key insights from the 2025 North American Imaging in MS Spinal Cord Imaging Workshop, highlighting recent advances, ongoing challenges, and future opportunities in MS spinal cord imaging. We review pathological studies and outline the clinical relevance of spinal cord lesions and atrophy for diagnosis, prognosis, and disease monitoring, highlighting emerging biomarkers of progression independent of relapse activity. Correlations between magnetic resonance imaging, histopathology, and clinical outcomes support the validation and translational potential of advanced spinal cord imaging techniques. Finally, we discuss spinal cord–specific processing pipelines and reproducibility challenges. Collectively, these insights underscore the need to integrate advanced and quantitative spinal cord imaging into clinical trials, research studies, and—when feasible—clinical care, to fully capture the extent of MS pathology, and ultimately improve patient outcomes.
- Open Access
- 21 April 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (6) , 557-567
Spinal cord imaging in multiple sclerosis: A vital component we can no longer overlook
Purpose: We conducted a systematic review to examine the use of spinal cord (SC) magnetic resonance imaging (MRI) in clinical trials for multiple sclerosis (MS) and discussed the significant challenges that impede its widespread implementation. Major findings: We identified 291 phase II and phase III clinical trials. Of these, 228 (78.4%) included at least one MRI outcome. Eight clinical trials (2.7%) were planned to include at least one SC MRI outcome, but only three (1.0%) reported related methodologies or results. The MRI metrics considered in these studies included cervical SC cross-sectional area (1.0%) and SC T 2 -lesion number (0.3%). Conclusion: A very small proportion of clinical trials have used SC MRI metrics as outcome measures. Given the substantial impact of SC disease on disability, it is essential to standardize SC imaging, post-processing, and analytical methods across centres to enhance the effectiveness and applicability of SC MRI in future clinical trials.
- 21 April 2026
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (6) , 557-567
Open AccessSpinal cord imaging in multiple sclerosis: A vital component we can no longer overlook
Purpose: We conducted a systematic review to examine the use of spinal cord (SC) magnetic resonance imaging (MRI) in clinical trials for multiple sclerosis (MS) and discussed the significant challenges that impede its widespread implementation. Major findings: We identified 291 phase II and phase III clinical trials. Of these, 228 (78.4%) included at least one MRI outcome. Eight clinical trials (2.7%) were planned to include at least one SC MRI outcome, but only three (1.0%) reported related methodologies or results. The MRI metrics considered in these studies included cervical SC cross-sectional area (1.0%) and SC T 2 -lesion number (0.3%). Conclusion: A very small proportion of clinical trials have used SC MRI metrics as outcome measures. Given the substantial impact of SC disease on disability, it is essential to standardize SC imaging, post-processing, and analytical methods across centres to enhance the effectiveness and applicability of SC MRI in future clinical trials.
- 1 October 2025
- Published by Frontline Medical Communications, Inc.
- Vol. 42 (10) , 365-371
Updates in Multiple Sclerosis Imaging
Multiple sclerosis (MS), one of the most common causes of neurological disability in young adults, is a chronic central nervous system disease characterized by immune-mediated inflammation, demyelination, and neurodegeneration. MS may be difficult to diagnose due to its protean neurological manifestations and the multitude of other neurologic conditions that can produce white matter lesions similar to MS demyelinating lesions. The wide clinical variability of the disease makes it challenging to provide an accurate prognosis in an individual with MS. Magnetic resonance imaging (MRI) biomarkers such as T2-lesions, chronic black holes, atrophy, paramagnetic rim lesions (PRL), and the central vein sign (CVS), may assist clinicians with the diagnosis and prognostication of MS. Underscoring their importance, PRL and CVS will be incorporated into the 2024 iteration of the McDonald Criteria for the diagnosis of MS. Quantitative MRI techniques, utilized in translational research, can quantify the degree of microstructural injury and guide the development of future therapies. This review discusses the impact, recent advances, and limitations of imaging biomarkers and quantitative MRI techniques with regard to routine MS clinical care and translational research. Clinicians caring for people with MS should have a basic understanding of imaging biomarkers and their implications for routine clinical care.
- 1 October 2025
- Published by Frontline Medical Communications, Inc.
- Vol. 42 (10) , 365-371
Updates in Multiple Sclerosis Imaging
Multiple sclerosis (MS), one of the most common causes of neurological disability in young adults, is a chronic central nervous system disease characterized by immune-mediated inflammation, demyelination, and neurodegeneration. MS may be difficult to diagnose due to its protean neurological manifestations and the multitude of other neurologic conditions that can produce white matter lesions similar to MS demyelinating lesions. The wide clinical variability of the disease makes it challenging to provide an accurate prognosis in an individual with MS. Magnetic resonance imaging (MRI) biomarkers such as T2-lesions, chronic black holes, atrophy, paramagnetic rim lesions (PRL), and the central vein sign (CVS), may assist clinicians with the diagnosis and prognostication of MS. Underscoring their importance, PRL and CVS will be incorporated into the 2024 iteration of the McDonald Criteria for the diagnosis of MS. Quantitative MRI techniques, utilized in translational research, can quantify the degree of microstructural injury and guide the development of future therapies. This review discusses the impact, recent advances, and limitations of imaging biomarkers and quantitative MRI techniques with regard to routine MS clinical care and translational research. Clinicians caring for people with MS should have a basic understanding of imaging biomarkers and their implications for routine clinical care.
- Open Access
- 16 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (12) , 2535-2545
The Associations Between Chronic Active Lesions and White Matter Disease: A 7 Tesla Imaging Study
Background: The relationship between paramagnetic rim lesions (PRLs) and surrounding normally appearing white matter (NAWM) disease, potentially contributory to the associations seen between PRLs and clinical impairment, is underexplored. Objectives: To assess whether PRLs correlate with a greater degree of NAWM injury in early MS. Methods: PRLs were identified on susceptibility weighted imaging (SWI) of 68 newly diagnosed patients. Each PRL was paired with an anatomically matched contralateral non‐PRL (nPRL) from the same participant. Quantitative magnetization transfer imaging derived macromolecular‐to‐free pool‐size ratio (PSR) and relaxation rate of the free water pool (R 1f ) values were extracted and compared between PRLs and nPRLs, NAWM surrounding PRLs and nPRLs, and whole brain WM lesions and NAWM of PRL+ and PRL− people with MS (pwMS). Results: PSR and R 1f ( p ≤ 0.028) values were lower in PRLs compared to nPRLs, but there were no differences in PSR and R 1f ( p ≥ 0.824) values between peri‐PRLs and peri‐nPRLs NAWM ROIs. PRL+ pwMS had similar PSR and R 1f ( p ≥ 0.267) of the whole brain NAWM, similar WM lesions PSR ( p = 0.764) but lower R 1f ( p = 0.030) values. Conclusions: In the early stages of MS, there is no association between PRLs and surrounding NAWM degree of injury.
- 16 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (12) , 2535-2545
Open AccessThe Associations Between Chronic Active Lesions and White Matter Disease: A 7 Tesla Imaging Study
Background: The relationship between paramagnetic rim lesions (PRLs) and surrounding normally appearing white matter (NAWM) disease, potentially contributory to the associations seen between PRLs and clinical impairment, is underexplored. Objectives: To assess whether PRLs correlate with a greater degree of NAWM injury in early MS. Methods: PRLs were identified on susceptibility weighted imaging (SWI) of 68 newly diagnosed patients. Each PRL was paired with an anatomically matched contralateral non‐PRL (nPRL) from the same participant. Quantitative magnetization transfer imaging derived macromolecular‐to‐free pool‐size ratio (PSR) and relaxation rate of the free water pool (R 1f ) values were extracted and compared between PRLs and nPRLs, NAWM surrounding PRLs and nPRLs, and whole brain WM lesions and NAWM of PRL+ and PRL− people with MS (pwMS). Results: PSR and R 1f ( p ≤ 0.028) values were lower in PRLs compared to nPRLs, but there were no differences in PSR and R 1f ( p ≥ 0.824) values between peri‐PRLs and peri‐nPRLs NAWM ROIs. PRL+ pwMS had similar PSR and R 1f ( p ≥ 0.267) of the whole brain NAWM, similar WM lesions PSR ( p = 0.764) but lower R 1f ( p = 0.030) values. Conclusions: In the early stages of MS, there is no association between PRLs and surrounding NAWM degree of injury.
- Open Access
- 10 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (11) , 1326-1337
Parasagittal dural space and arachnoid granulations morphology in pre-clinical and early clinical multiple sclerosis
Background: There is limited knowledge on the post-glymphatic structures such as the parasagittal dural (PSD) space and the arachnoid granulations (AGs) in multiple sclerosis (MS). Objectives: To evaluate differences in volume and macromolecular content of PSD and AG between people with newly diagnosed MS (pwMS), clinically isolated syndrome (pwCIS), or radiologically isolated syndrome (pwRIS) and healthy controls (HCs) and their associations with clinical and radiological disease measures. Methods: A total of 69 pwMS, pwCIS, pwRIS, and HCs underwent a 3.0 Tesla magnetic resonance imaging (MRI) including selective inversion recovery quantitative magnetization transfer imaging to compute the macromolecular-to-free water pool-size-ratio (PSR) and the free water relaxation rate (R 1f ), T 2 -weighted (T 2 -w) volumetric isotropic turbo-spin-echo to segment the PSD and AG, T 2 -w fluid-attenuated inversion recovery images to compute T 2 -lesions burden, and a T 1 -w sequence to quantify chronic black holes (cBHs) burden and brain parenchymal fraction. Results: After adjusting for age and sex, larger frontal ( p = 0.006) and parietal ( p = 0.047) PSD volumes along with larger parietal AG volumes ( p = 0.033) were measured in patients compared to HCs. Parietal PSD volume correlated with cBH PSR ( r = −0.430, p = 0.032). Conclusion: Upon diagnosis, enlarged structures in the post-glymphatic system may be observed, indicating a need for further investigation of their role.
- 10 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (11) , 1326-1337
Open AccessParasagittal dural space and arachnoid granulations morphology in pre-clinical and early clinical multiple sclerosis
Background: There is limited knowledge on the post-glymphatic structures such as the parasagittal dural (PSD) space and the arachnoid granulations (AGs) in multiple sclerosis (MS). Objectives: To evaluate differences in volume and macromolecular content of PSD and AG between people with newly diagnosed MS (pwMS), clinically isolated syndrome (pwCIS), or radiologically isolated syndrome (pwRIS) and healthy controls (HCs) and their associations with clinical and radiological disease measures. Methods: A total of 69 pwMS, pwCIS, pwRIS, and HCs underwent a 3.0 Tesla magnetic resonance imaging (MRI) including selective inversion recovery quantitative magnetization transfer imaging to compute the macromolecular-to-free water pool-size-ratio (PSR) and the free water relaxation rate (R 1f ), T 2 -weighted (T 2 -w) volumetric isotropic turbo-spin-echo to segment the PSD and AG, T 2 -w fluid-attenuated inversion recovery images to compute T 2 -lesions burden, and a T 1 -w sequence to quantify chronic black holes (cBHs) burden and brain parenchymal fraction. Results: After adjusting for age and sex, larger frontal ( p = 0.006) and parietal ( p = 0.047) PSD volumes along with larger parietal AG volumes ( p = 0.033) were measured in patients compared to HCs. Parietal PSD volume correlated with cBH PSR ( r = −0.430, p = 0.032). Conclusion: Upon diagnosis, enlarged structures in the post-glymphatic system may be observed, indicating a need for further investigation of their role.
- Open Access
- 1 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (10) , 1205-1217
Comparing the macromolecular-to-free pool size ratio and the magnetization transfer ratio for the assessment of myelin injury in early multiple sclerosis
Background: The selective inversion recovery quantitative magnetization transfer imaging-derived macromolecular-to-free pool size ratio (PSR) and the magnetization transfer imaging-derived magnetization transfer ratio (MTR) are both indirect indicators of myelin integrity. However, it remains unknown whether the two measures perform equally in clinical studies. Objectives: To compare the accuracy and effect size (ES) of PSR and MTR in assessing white matter (WM) injury in the brain of people with multiple sclerosis (PwMS). Methods: MTR and PSR were measured in lesions and normal-appearing white matter (NAWM) of 40 PwMS and in the normal white matter (NWM) of 16 healthy controls (HCs). Results: In total, 231 T 2 -lesions, 257 chronic black holes (cBHs), 450 regions of interest (ROIs) in NAWM proximal (pNAWM) and distant (dNAWM) to lesions of PwMS, and 150 NWM ROIs of HCs were assessed. PSR was more accurate ( p ⩽ 0.046) and had higher ES ( p < 0.001) than MTR in differentiating T 2 -lesions from pNAWM, dNAWM, or NWM. PSR was more accurate ( p = 0.006) than MTR in differentiating cBHs from NWM and showed higher ES ( p = 0.003) when comparing cBHs with pNAWM and dNAWM. Conclusions: PSR has greater accuracy and ES than MTR in distinguishing WM areas with different degrees of tissue injury.
- 1 September 2025
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 31 (10) , 1205-1217
Open AccessComparing the macromolecular-to-free pool size ratio and the magnetization transfer ratio for the assessment of myelin injury in early multiple sclerosis
Background: The selective inversion recovery quantitative magnetization transfer imaging-derived macromolecular-to-free pool size ratio (PSR) and the magnetization transfer imaging-derived magnetization transfer ratio (MTR) are both indirect indicators of myelin integrity. However, it remains unknown whether the two measures perform equally in clinical studies. Objectives: To compare the accuracy and effect size (ES) of PSR and MTR in assessing white matter (WM) injury in the brain of people with multiple sclerosis (PwMS). Methods: MTR and PSR were measured in lesions and normal-appearing white matter (NAWM) of 40 PwMS and in the normal white matter (NWM) of 16 healthy controls (HCs). Results: In total, 231 T 2 -lesions, 257 chronic black holes (cBHs), 450 regions of interest (ROIs) in NAWM proximal (pNAWM) and distant (dNAWM) to lesions of PwMS, and 150 NWM ROIs of HCs were assessed. PSR was more accurate ( p ⩽ 0.046) and had higher ES ( p < 0.001) than MTR in differentiating T 2 -lesions from pNAWM, dNAWM, or NWM. PSR was more accurate ( p = 0.006) than MTR in differentiating cBHs from NWM and showed higher ES ( p = 0.003) when comparing cBHs with pNAWM and dNAWM. Conclusions: PSR has greater accuracy and ES than MTR in distinguishing WM areas with different degrees of tissue injury.
- 30 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf215
Paramagnetic rim lesions in early multiple sclerosis: a 7 Tesla imaging study
Paramagnetic rim lesions (PRL) are considered biomarkers of chronic active lesions (CAL) in multiple sclerosis. The chronological relationship between CAL and disease severity in multiple sclerosis is not fully defined. In this cross-sectional, prospective study, we investigate the relationship between PRL and clinical/radiological measures of disease severity at the time of diagnosis of multiple sclerosis, clinically isolated syndrome, or radiologically isolated syndrome. Sixty-four treatment naïve people with newly diagnosed multiple sclerosis, clinically isolated syndrome, or radiologically isolated syndrome were consecutively enrolled. Each subject underwent 7.0 Tesla magnetic resonance imaging (MRI) and neurocognitive assessments. The MRI protocol included whole brain 3-dimensional acquisitions of: (i) magnetisation prepared 2 rapid gradient echoes, T2-weighted fluid attenuated inversion recovery, and (ii) single echo gradient echo susceptibility sequences, from which susceptibility weighted imaging maps were derived. Differences in clinical and radiological metrics between people with and without PRL were assessed using a Welch's two-sample t-test (continuous variables) and Pearson's Chi-square test (categorical variables). Associations between clinical and radiological variables were measured using Pearson's correlation analyses. Two subjects were eliminated from the analyses for the following reasons: one subject was receiving a disease-modifying agent at the time of the 7.0 Tesla MRI, and the second had several tumefactive and confluent T2-lesions which could have biased the results. PRL were detected in 29 of 62 (46.8%) people. PRL positive people had a larger T2-lesion burden and lower normalized volumes of the thalamus and amygdala, as well as thinning of a few cortical regions (P ≤ 0.05). PRL positive individuals performed worse on the 9-hole Peg Test (non-dominant hand) and the Brief Visuospatial Memory Test—revised (total recall component) (P ≤ 0.05). Some of these differences were lost upon Bonferroni correction. We demonstrate that as early as the time of diagnosis, the presence of PRL is associated with a few clinical and radiological measures of disease severity. Thus, PRL can be considered qualitative indicators of a more aggressive disease presentation.
- 30 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf215
Paramagnetic rim lesions in early multiple sclerosis: a 7 Tesla imaging study
Paramagnetic rim lesions (PRL) are considered biomarkers of chronic active lesions (CAL) in multiple sclerosis. The chronological relationship between CAL and disease severity in multiple sclerosis is not fully defined. In this cross-sectional, prospective study, we investigate the relationship between PRL and clinical/radiological measures of disease severity at the time of diagnosis of multiple sclerosis, clinically isolated syndrome, or radiologically isolated syndrome. Sixty-four treatment naïve people with newly diagnosed multiple sclerosis, clinically isolated syndrome, or radiologically isolated syndrome were consecutively enrolled. Each subject underwent 7.0 Tesla magnetic resonance imaging (MRI) and neurocognitive assessments. The MRI protocol included whole brain 3-dimensional acquisitions of: (i) magnetisation prepared 2 rapid gradient echoes, T2-weighted fluid attenuated inversion recovery, and (ii) single echo gradient echo susceptibility sequences, from which susceptibility weighted imaging maps were derived. Differences in clinical and radiological metrics between people with and without PRL were assessed using a Welch's two-sample t-test (continuous variables) and Pearson's Chi-square test (categorical variables). Associations between clinical and radiological variables were measured using Pearson's correlation analyses. Two subjects were eliminated from the analyses for the following reasons: one subject was receiving a disease-modifying agent at the time of the 7.0 Tesla MRI, and the second had several tumefactive and confluent T2-lesions which could have biased the results. PRL were detected in 29 of 62 (46.8%) people. PRL positive people had a larger T2-lesion burden and lower normalized volumes of the thalamus and amygdala, as well as thinning of a few cortical regions (P ≤ 0.05). PRL positive individuals performed worse on the 9-hole Peg Test (non-dominant hand) and the Brief Visuospatial Memory Test—revised (total recall component) (P ≤ 0.05). Some of these differences were lost upon Bonferroni correction. We demonstrate that as early as the time of diagnosis, the presence of PRL is associated with a few clinical and radiological measures of disease severity. Thus, PRL can be considered qualitative indicators of a more aggressive disease presentation.
- Open Access
- 24 December 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (1) , fcaf011
Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation
Quantitative susceptibility mapping and phase imaging are used to identify multiple sclerosis lesions with paramagnetic rims that slowly expand over time and are associated with earlier progression to disability, decreased brain volume and increased frequency of clinical relapse. However, the presence of iron-laden microglia/macrophages at the lesion rim and demyelination within the lesion both contribute to phase and quantitative susceptibility mapping images. Therefore, simultaneous pathological validation is needed to assess accuracies in identifying iron-positive lesions. MRI was performed on 15 multiple sclerosis brain slabs; 32 lesions of interest were processed for myelin, iron and microglial markers. Three experienced readers classified lesions as rim positive or negative on quantitative susceptibility mapping and phase; these classifications were compared with Perls’ stain as the gold standard. All 10 of the quantitative susceptibility mapping-positive lesions had iron-positive rims on histology. Of the 16 phase-positive lesions, only 10 had iron-positive rims on histology. Using Perls’ stain as the ground truth, the positive predictive value was 100% for quantitative susceptibility mapping and 63% for phase; the negative predictive value was 95% for quantitative susceptibility mapping and 94% for phase. Post-mortem imaging results demonstrate that quantitative susceptibility mapping is a more reliable indicator of an iron-positive rim compared with phase imaging.
- 24 December 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (1) , fcaf011
Open AccessQuantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation
Quantitative susceptibility mapping and phase imaging are used to identify multiple sclerosis lesions with paramagnetic rims that slowly expand over time and are associated with earlier progression to disability, decreased brain volume and increased frequency of clinical relapse. However, the presence of iron-laden microglia/macrophages at the lesion rim and demyelination within the lesion both contribute to phase and quantitative susceptibility mapping images. Therefore, simultaneous pathological validation is needed to assess accuracies in identifying iron-positive lesions. MRI was performed on 15 multiple sclerosis brain slabs; 32 lesions of interest were processed for myelin, iron and microglial markers. Three experienced readers classified lesions as rim positive or negative on quantitative susceptibility mapping and phase; these classifications were compared with Perls’ stain as the gold standard. All 10 of the quantitative susceptibility mapping-positive lesions had iron-positive rims on histology. Of the 16 phase-positive lesions, only 10 had iron-positive rims on histology. Using Perls’ stain as the ground truth, the positive predictive value was 100% for quantitative susceptibility mapping and 63% for phase; the negative predictive value was 95% for quantitative susceptibility mapping and 94% for phase. Post-mortem imaging results demonstrate that quantitative susceptibility mapping is a more reliable indicator of an iron-positive rim compared with phase imaging.
- Open Access
- 10 December 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2444-2454
Improving the Detection of Myelin Integrity in Multiple Sclerosis Using Selective Inversion Recovery for MRI With Quantitative Magnetization Transfer
Background: Selective inversion recovery quantitative magnetization transfer (SIR‐qMT)‐derived macromolecular to free water pool size ratio (PSR) and diffusion tensor imaging (DTI)‐derived radial diffusivity (RD) are potential metrics for assessing myelin integrity in multiple sclerosis (MS). However, establishing their accuracy in identifying tissue injury is essential for clinical translation.Purpose: To compare the accuracy and Cohen's effect size (ES) of PSR and RD in detecting and quantifying tissue injury in early MS.Study Type: Cross‐sectional prospective study.Subjects: Fourty‐three subjects with newly diagnosed MS (mean age 38 ± 11 years, 70% females) and 18 age‐ and sex‐matched healthy controls (HCs; age 38 ± 12 years, 62.5% females).Field Strength/Sequence: 3‐T MRI using T1‐weighted (T1‐w) turbo spin echo, T2‐w fluid‐attenuated inversion recovery (FLAIR), DTI, and SIR‐qMT sequences.Assessment: T2‐lesions were identified as hyperintense on T2‐w‐FLAIR, and chronic black holes (cBHs) by simultaneous T2‐w‐FLAIR hyperintensity and T1‐w hypointensity. Regions of interest (ROIs) in normal‐appearing white matter (NAWM) were classified as proximal (p) or distant (d) to lesions, while normal white matter (NWM) was identified in HCs. PSR and RD values of T2‐lesions and cBHs were compared to their matched p/dNAWM and NWM in HCs. Comparisons were also made between T2‐lesions and cBHs.Statistical Tests: Receiver operating characteristic curves evaluated metric accuracy, and paired t tests compared ES values of PSR and RD, with significance set at P < 0.050.Results: We identified 823 T2‐lesions, 392 cBHs, 426 p‐, and 213 d‐NAWM ROIs in patients, and 162 NWM ROIs in HCs. PSR differed significantly in all comparisons, while RD was differed in all except cBHs vs. T2‐lesions (P = 0.051). PSR had significantly higher accuracy in differentiating T2‐lesions from p/dNAWM and NWM, with a larger ES when comparing T2‐lesions to p/dNAWM and NWM and cBHs to pNAWM and NWM.Data Conclusion: PSR offers superior accuracy and ES over RD in detecting tissue injury in MS.Level of Evidence: 1Technical Efficacy: Stage 2
- 10 December 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2444-2454
Open AccessImproving the Detection of Myelin Integrity in Multiple Sclerosis Using Selective Inversion Recovery for MRI With Quantitative Magnetization Transfer
Background: Selective inversion recovery quantitative magnetization transfer (SIR‐qMT)‐derived macromolecular to free water pool size ratio (PSR) and diffusion tensor imaging (DTI)‐derived radial diffusivity (RD) are potential metrics for assessing myelin integrity in multiple sclerosis (MS). However, establishing their accuracy in identifying tissue injury is essential for clinical translation.Purpose: To compare the accuracy and Cohen's effect size (ES) of PSR and RD in detecting and quantifying tissue injury in early MS.Study Type: Cross‐sectional prospective study.Subjects: Fourty‐three subjects with newly diagnosed MS (mean age 38 ± 11 years, 70% females) and 18 age‐ and sex‐matched healthy controls (HCs; age 38 ± 12 years, 62.5% females).Field Strength/Sequence: 3‐T MRI using T1‐weighted (T1‐w) turbo spin echo, T2‐w fluid‐attenuated inversion recovery (FLAIR), DTI, and SIR‐qMT sequences.Assessment: T2‐lesions were identified as hyperintense on T2‐w‐FLAIR, and chronic black holes (cBHs) by simultaneous T2‐w‐FLAIR hyperintensity and T1‐w hypointensity. Regions of interest (ROIs) in normal‐appearing white matter (NAWM) were classified as proximal (p) or distant (d) to lesions, while normal white matter (NWM) was identified in HCs. PSR and RD values of T2‐lesions and cBHs were compared to their matched p/dNAWM and NWM in HCs. Comparisons were also made between T2‐lesions and cBHs.Statistical Tests: Receiver operating characteristic curves evaluated metric accuracy, and paired t tests compared ES values of PSR and RD, with significance set at P < 0.050.Results: We identified 823 T2‐lesions, 392 cBHs, 426 p‐, and 213 d‐NAWM ROIs in patients, and 162 NWM ROIs in HCs. PSR differed significantly in all comparisons, while RD was differed in all except cBHs vs. T2‐lesions (P = 0.051). PSR had significantly higher accuracy in differentiating T2‐lesions from p/dNAWM and NWM, with a larger ES when comparing T2‐lesions to p/dNAWM and NWM and cBHs to pNAWM and NWM.Data Conclusion: PSR offers superior accuracy and ES over RD in detecting tissue injury in MS.Level of Evidence: 1Technical Efficacy: Stage 2